President Donald Trump signed an Executive Order (EO) titled “Lowering Drug Prices by Once Again Putting Americans First,” outlining ...

Novo Nordisk argues Medicare should negotiate the price for six of its insulin products separately, though they contain the ...

Key Takeaways The U.S. Food and Drug Administration may hand off routine food inspections to state and local officialsThe FDA ...

The FDA had rejected the companies’ initial application in 2023, requesting additional data after the pharma firms reported ...

Independence Health Group, the parent company of Independence Blue Cross, spent $500 million last year to provide ...

Trump signed an executive order on Tuesday telling the Department of Health and Human Services to take steps to lower drug prices.

Providers on Wednesday embraced the CMS decision to extend the deadline for its mandatory nursing home revalidation program.

A federal judge who blocked Donald Trump’s administration from dismantling the Consumer Financial Protection Bureau has ruled ...

As CMS maintains limits on GLP-1 coverage for weight loss, new efficacy data and shifting prescribing patterns point to sustained high demand across the drug class. Here are four updates: 1. Federal ...

According to KFF’s research, the new Trump executive order on small molecule drugs could lead to higher Medicare prescription ...

An internal memo proposes carving out $40 billion from federal health agencies while eliminating dozens of programs. Congress ...

RFK Jr.'s dehumanizing language is both inaccurate and wildly insulting. It's the language of those who think kids with ...